210 related articles for article (PubMed ID: 38515051)
21. CT-based radiomics analysis of different machine learning models for differentiating benign and malignant parotid tumors.
Zheng Y; Zhou D; Liu H; Wen M
Eur Radiol; 2022 Oct; 32(10):6953-6964. PubMed ID: 35484339
[TBL] [Abstract][Full Text] [Related]
22. Preoperative Diagnosis of Dual-Phenotype Hepatocellular Carcinoma Using Enhanced MRI Radiomics Models.
Wu Q; Yu YX; Zhang T; Zhu WJ; Fan YF; Wang XM; Hu CH
J Magn Reson Imaging; 2023 Apr; 57(4):1185-1196. PubMed ID: 36190656
[TBL] [Abstract][Full Text] [Related]
23. Machine-learning-based contrast-enhanced computed tomography radiomic analysis for categorization of ovarian tumors.
Li J; Zhang T; Ma J; Zhang N; Zhang Z; Ye Z
Front Oncol; 2022; 12():934735. PubMed ID: 36016613
[TBL] [Abstract][Full Text] [Related]
24. A clinical-radiomic-pathomic model for prognosis prediction in patients with hepatocellular carcinoma after radical resection.
Xie Q; Zhao Z; Yang Y; Wang X; Wu W; Jiang H; Hao W; Peng R; Luo C
Cancer Med; 2024 Jun; 13(11):e7374. PubMed ID: 38864473
[TBL] [Abstract][Full Text] [Related]
25. Non-Contrasted CT Radiomics for SAH Prognosis Prediction.
Shan D; Wang J; Qi P; Lu J; Wang D
Bioengineering (Basel); 2023 Aug; 10(8):. PubMed ID: 37627852
[TBL] [Abstract][Full Text] [Related]
26. Development of a machine learning-based model to predict prognosis of alpha-fetoprotein-positive hepatocellular carcinoma.
Dong B; Zhang H; Duan Y; Yao S; Chen Y; Zhang C
J Transl Med; 2024 May; 22(1):455. PubMed ID: 38741163
[TBL] [Abstract][Full Text] [Related]
27. Radiomics for diagnosis of dual-phenotype hepatocellular carcinoma using Gd-EOB-DTPA-enhanced MRI and patient prognosis.
Huang X; Long L; Wei J; Li Y; Xia Y; Zuo P; Chai X
J Cancer Res Clin Oncol; 2019 Dec; 145(12):2995-3003. PubMed ID: 31664520
[TBL] [Abstract][Full Text] [Related]
28. Development and validation of a combined nomogram for predicting perineural invasion status in rectal cancer via computed tomography-based radiomics.
Liu J; Sun L; Zhao X; Lu X
J Cancer Res Ther; 2023 Dec; 19(6):1552-1559. PubMed ID: 38156921
[TBL] [Abstract][Full Text] [Related]
29. T2-weighted imaging-based radiomic-clinical machine learning model for predicting the differentiation of colorectal adenocarcinoma.
Zheng HD; Huang QY; Huang QM; Ke XT; Ye K; Lin S; Xu JH
World J Gastrointest Oncol; 2024 Mar; 16(3):819-832. PubMed ID: 38577440
[TBL] [Abstract][Full Text] [Related]
30. A radiomics-based biomarker for cytokeratin 19 status of hepatocellular carcinoma with gadoxetic acid-enhanced MRI.
Wang W; Gu D; Wei J; Ding Y; Yang L; Zhu K; Luo R; Rao SX; Tian J; Zeng M
Eur Radiol; 2020 May; 30(5):3004-3014. PubMed ID: 32002645
[TBL] [Abstract][Full Text] [Related]
31. MRI radiomics to monitor therapeutic outcome of sorafenib plus IHA transcatheter NK cell combination therapy in hepatocellular carcinoma.
Yu G; Zhang Z; Eresen A; Hou Q; Garcia EE; Yu Z; Abi-Jaoudeh N; Yaghmai V; Zhang Z
J Transl Med; 2024 Jan; 22(1):76. PubMed ID: 38243292
[TBL] [Abstract][Full Text] [Related]
32. Radiomic analysis of Gd-EOB-DTPA-enhanced MRI predicts Ki-67 expression in hepatocellular carcinoma.
Fan Y; Yu Y; Wang X; Hu M; Hu C
BMC Med Imaging; 2021 Jun; 21(1):100. PubMed ID: 34130644
[TBL] [Abstract][Full Text] [Related]
33. Influence of different region of interest sizes on CT-based radiomics model for microvascular invasion prediction in hepatocellular carcinoma.
Zhao H; Feng Z; Li H; Yao S; Zheng W; Rong P
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Aug; 47(8):1049-1057. PubMed ID: 36097772
[TBL] [Abstract][Full Text] [Related]
34. Radiomics-based Machine Learning to Predict the Recurrence of Hepatocellular Carcinoma: A Systematic Review and Meta-analysis.
Jin J; Jiang Y; Zhao YL; Huang PT
Acad Radiol; 2024 Feb; 31(2):467-479. PubMed ID: 37867018
[TBL] [Abstract][Full Text] [Related]
35. Preoperative classification of primary and metastatic liver cancer via machine learning-based ultrasound radiomics.
Mao B; Ma J; Duan S; Xia Y; Tao Y; Zhang L
Eur Radiol; 2021 Jul; 31(7):4576-4586. PubMed ID: 33447862
[TBL] [Abstract][Full Text] [Related]
36. Prediction of therapeutic response of unresectable hepatocellular carcinoma to hepatic arterial infusion chemotherapy based on pretherapeutic MRI radiomics and Albumin-Bilirubin score.
Zhao Y; Huang F; Liu S; Jian L; Xia X; Lin H; Liu J
J Cancer Res Clin Oncol; 2023 Jul; 149(8):5181-5192. PubMed ID: 36369395
[TBL] [Abstract][Full Text] [Related]
37. Deep Learning Radiomics Model of Dynamic Contrast-Enhanced MRI for Evaluating Vessels Encapsulating Tumor Clusters and Prognosis in Hepatocellular Carcinoma.
Dong X; Yang J; Zhang B; Li Y; Wang G; Chen J; Wei Y; Zhang H; Chen Q; Jin S; Wang L; He H; Gan M; Ji W
J Magn Reson Imaging; 2024 Jan; 59(1):108-119. PubMed ID: 37078470
[TBL] [Abstract][Full Text] [Related]
38. Reproducibility and non-redundancy of radiomic features extracted from arterial phase CT scans in hepatocellular carcinoma patients: impact of tumor segmentation variability.
Qiu Q; Duan J; Duan Z; Meng X; Ma C; Zhu J; Lu J; Liu T; Yin Y
Quant Imaging Med Surg; 2019 Mar; 9(3):453-464. PubMed ID: 31032192
[TBL] [Abstract][Full Text] [Related]
39. Considerable effects of imaging sequences, feature extraction, feature selection, and classifiers on radiomics-based prediction of microvascular invasion in hepatocellular carcinoma using magnetic resonance imaging.
Dai H; Lu M; Huang B; Tang M; Pang T; Liao B; Cai H; Huang M; Zhou Y; Chen X; Ding H; Feng ST
Quant Imaging Med Surg; 2021 May; 11(5):1836-1853. PubMed ID: 33936969
[TBL] [Abstract][Full Text] [Related]
40. MRI radiomics-based machine learning model integrated with clinic-radiological features for preoperative differentiation of sinonasal inverted papilloma and malignant sinonasal tumors.
Gu J; Yu Q; Li Q; Peng J; Lv F; Gong B; Zhang X
Front Oncol; 2022; 12():1003639. PubMed ID: 36212455
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
